CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...

CVS Health Corp issued an optimistic guidance for 2025 stemming from the expected recovery in its insurance business — ...

CVS Health CVS turned in solid fourth-quarter results, and its 2025 guidance for 6%-11% adjusted EPS growth without any share ...

Shares of CVS Health Corp. were having their best day in 26 years on Wednesday, after the drugstore chain and healthcare-services company beat quarterly profit expectations by a wide margin, and as ...

Asian markets closed mostly higher on Wednesday, with Japan's Nikkei 225 gaining 0.42%, China's Shanghai Composite Index ...

CVS Health reported Q4 2024 profits of $1.6 billion, down from $2 billion, with annual profits at $4.6 billion, down $8.3 billion in 2023.

U.S. stocks pared early losses on Wednesday but remained mostly lower after inflation data came in hotter than expected, potentially complicating the Federal Reserve's job of returning inflation to ...

CVS, which operates the nation's largest pharmacy chain, health insurer Aetna, and the pharmacy benefit manager Caremark, beat estimates on the top and bottom lines in the fourth quarter. Revenue rose ...

The earnings surpassed analyst expectations with an adjusted earnings per share (EPS) of $1.19, beating estimates of $0.91 by ...

CVS Health Corp (NYSE:CVS) reported a strong finish to 2024, surpassing earnings and revenue forecasts for the fourth quarter. The company posted earnings per share (EPS) of $1.19, beating the ...

CEO David Joyner highlighted the company's Q4 adjusted EPS of $1.19 and adjusted operating income of $2.7 billion. He introduced 2025 adjusted EPS guidance of $5.75 to $6.00, emphasizing recovery in ...

CVS Health Corporation CVS posted adjusted earnings per share (EPS) of $1.19 in the fourth quarter of 2024, down 43.9% year ...